Healius Ltd
ASX:HLS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.1
1.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Healius Ltd
Net Issuance of Common Stock
Healius Ltd
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Healius Ltd
ASX:HLS
|
Net Issuance of Common Stock
AU$179.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Net Issuance of Common Stock
AU$13.4m
|
CAGR 3-Years
151%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Net Issuance of Common Stock
AU$194.4m
|
CAGR 3-Years
54%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
18%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Net Issuance of Common Stock
AU$1.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Net Issuance of Common Stock
AU$518k
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Net Issuance of Common Stock
-AU$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Healius Ltd
Glance View
Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.
See Also
What is Healius Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
179.3m
AUD
Based on the financial report for Jun 30, 2024, Healius Ltd's Net Issuance of Common Stock amounts to 179.3m AUD.
What is Healius Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-6%
You don't have any saved screeners yet
